It has been shown that TACE has a synergistic effect with systemic therapies because it upregulates the expressions of fibroblast growth factor (FGF) and VEGF (7), and stimulates tumor-associated antigens release and immunogenic death of cancer cells (8, 9). This evidence concerns the gene VEGFA and neoplasm.